Polymorphisms in inflammatory and immune response genes associated with cerebral cavernous malformation type 1 severity.
about
Neurocysticercosis, familial cerebral cavernomas and intracranial calcifications: differential diagnosis for adequate management.Genetics of cerebral cavernous malformations: current status and future prospectsVascular permeability in cerebral cavernous malformations.Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1.Peripheral plasma vitamin D and non-HDL cholesterol reflect the severity of cerebral cavernous malformation disease.Up-regulation of NADPH oxidase-mediated redox signaling contributes to the loss of barrier function in KRIT1 deficient endothelium.Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations.B-Cell Depletion Reduces the Maturation of Cerebral Cavernous Malformations in Murine Models.Oxidative stress and inflammation in cerebral cavernous malformation disease pathogenesis: Two sides of the same coin.Update on Novel CCM Gene Mutations in Patients with Cerebral Cavernous Malformations.Micro-computed tomography in murine models of cerebral cavernous malformations as a paradigm for brain disease.Endothelial TLR4 and the microbiome drive cerebral cavernous malformations.Perivascular neurotransmitters: Regulation of cerebral blood flow and role in primary headaches.Rebleeding and Outcome in Patients with Symptomatic Brain Stem Cavernomas.
P2860
Q31109915-AE0DC153-00EC-47B4-B11F-DE0FC41B6146Q35706117-47CC340B-4A93-4E0A-B79C-86E322DCBDABQ36267403-EB1B2C59-574F-4852-9901-5A3C55A26ED0Q36641687-562107BC-17F1-4DF6-B444-00865CD90518Q37050968-FB419F1B-286B-493C-B4BF-40E0C8581ECCQ38622980-ECE4C42B-58A9-4505-85FC-E6F087378D7DQ38640436-44068A92-C028-4EF7-ABF2-AC6600395B6BQ38880171-A8CC5B2F-DDFF-4B2F-8501-7A7933CF7773Q38957623-29E4E232-5AD8-4195-A652-6BE3FF78D3DCQ39079343-E443D261-3C6B-4ADA-BF21-8573D5B778D4Q40968561-9F4D086A-E942-4CDA-B1F9-4FAE55CDCCCBQ46180887-4D6C161A-8B95-4146-BEF3-D0326694D0F8Q47676203-430968C4-8C1E-4FDE-A3ED-E2AE0762D641Q48256054-E540809C-E687-4B6F-BA01-28EF7123B404
P2860
Polymorphisms in inflammatory and immune response genes associated with cerebral cavernous malformation type 1 severity.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Polymorphisms in inflammatory ...... malformation type 1 severity.
@ast
Polymorphisms in inflammatory ...... malformation type 1 severity.
@en
Polymorphisms in inflammatory ...... malformation type 1 severity.
@nl
type
label
Polymorphisms in inflammatory ...... malformation type 1 severity.
@ast
Polymorphisms in inflammatory ...... malformation type 1 severity.
@en
Polymorphisms in inflammatory ...... malformation type 1 severity.
@nl
prefLabel
Polymorphisms in inflammatory ...... malformation type 1 severity.
@ast
Polymorphisms in inflammatory ...... malformation type 1 severity.
@en
Polymorphisms in inflammatory ...... malformation type 1 severity.
@nl
P2093
P2860
P50
P356
P1476
Polymorphisms in inflammatory ...... malformation type 1 severity.
@en
P2093
Blaine Hart
Brain Vascular Malformation Consortium (BVMC) Study
Charles E McCulloch
Jeffrey Nelson
Ludmila Pawlikowska
Yasir Khan
P2860
P304
P356
10.1159/000369200
P577
2014-12-03T00:00:00Z